“ We are steadily transforming from a relatively smaller player in generics and early-phase clinical studies to a broader and more relevant Contract Research Organization for our… ”
In Conversation
“ While generics continue to be a core focus, there has been a strategic shift towards emphasising innovation ”
“ Leveraging this resource [the Systeme National des Donnees de Sante (SNDS)], we conduct numerous real-world studies, positioning France among the leaders in real-world evidence generation within… ”
“ Over the next three years, our focus is set on three fundamental elements to drive growth and impact: portfolio transformation, capability building, and expanding the HCP… ”
“ Our collective journey to build a leading international dermatology company in India has just begun, and I am confident that with the dedication, passion, and unwavering… ”
Saskia Steinacker – Senior Vice President, Global Head Strategy and Digital Transformation (IT), Bayer
“ [We must] avoid placing AI at the centre and then working backwards to find a problem. Instead, we should take a problem-centric approach, identifying real-world challenges… ”
“ Our aspirations are ambitious, aiming for a three-fold increase in size over the next 8-10 years ”
“ We have the experience, the footprint, the governance, and the ambition to leverage the opportunities ahead and forge a new path for pharmaceuticals in Gujarat ”
Monica Bettencourt-Dias – Principal Investigator & Former Director, Gulbenkian Institute for Science (IGC)
“ The funding landscape for science in Portugal is facing challenges that stem from a decrease in overall investment and shifting priorities. Despite the evident role of… ”
“ Our broad, global portfolio includes products that help treat the top 10 leading causes of death globally, as determined by the WHO ”
“ We are committed to finding a balanced approach that considers both the imperative of enabling better health outcomes and the need for ensuring the sustainability of… ”
“ We actively sought out synergies in the diagnostic business and view partnerships as a means to avoid reinventing the wheel ”